SCHEMBL3618672

SCHEMBL3618672

c1ccc2cc(-c3ccsn3)ccc2c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 4/20 0.56
ALDH1A1 P00352 3/20 0.56
CYP2C9 P11712 1/20 0.56
HPGD P15428 1/20 0.56
CYP2C19 P33261 1/20 0.56
NPSR1 Q6W5P4 1/20 0.56
SMN1; SMN2 Q16637 4/20 0.51
NPC1 O15118 4/20 0.51
RAB9A P51151 4/20 0.51
AR P10275 2/20 0.51
MAPT P10636 2/20 0.51
KDM4E B2RXH2 1/20 0.51
NFKB1 P19838 1/20 0.51
GFER P55789 1/20 0.51
NFKB2 Q00653 1/20 0.51
RELA Q04206 1/20 0.51
CYP1A1 P04798 1/20 0.47
CYP1B1 Q16678 1/20 0.47
CYP11B1 P15538 2/20 0.43
CYP11B2 P19099 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2457599 0.73 NPC1 (0.51) NPSR1NPC1MAPTCYP11B1CYP11B2
SCHEMBL10051451 0.73 CYP1A2 (0.70) CYP1A2ALDH1A1CYP2C9HPGDCYP2C19
SCHEMBL12655974 0.73 CYP1A2 (0.59) CYP1A2ALDH1A1CYP2C9HPGDCYP2C19
SCHEMBL27962029 0.72 ALDH1A1 (1.00) CYP1A2ALDH1A1CYP2C9HPGDCYP2C19
SCHEMBL10051442 0.71 CYP1A2 (0.62) CYP1A2ALDH1A1CYP2C9HPGDCYP2C19
SCHEMBL30239993 0.71 ESR1 (0.71) CYP1A2ALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL15902840 0.71 ESR1 (0.71) CYP1A2ALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL30603836 0.71 ESR1 (0.71) CYP1A2ALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL5013872 0.71 ESR1 (0.71) CYP1A2ALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL239121 0.71 ESR1 (0.71) CYP1A2ALDH1A1SMN1; SMN2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112552257-A 3, 5-disubstituted isothiazole compound and synthesis method and application thereof 五邑大学 2021-03-26 CN claimed
CN-112552257-A 3, 5-disubstituted isothiazole compound and synthesis method and application thereof 五邑大学 2021-03-26 CN disclosed
US-20100317703-A1 METHOD FOR INHIBITING BRASSININ OXIDASE UNIVERSITY OF SASKATCHEWAN (CA) 2010-12-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100317703-A1 METHOD FOR INHIBITING BRASSININ OXIDASE BROX, BLVRB, BBOX1 CYP1A2 1667/4885ALDH1A1 3166/4885CYP2C9 2211/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.